GlassScriptPhysician profile
Brian J Vial
NPI 1295155570
$5,785.91
in general payments reported to CMS, 2019-2025
13 companies · $71.44 in 2025
The $71.44 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,606 · 2020: $1,386 · 2021: $380 · 2022: $1,264 · 2023: $37.05 · 2024: $40.85 · 2025: $71.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,332.02 | 2019-2021 | |
| Medinc of Texas | $2,318.38 | 2020-2024 | |
| Depuy Synthes Sales INC. | $263.39 | 2019-2024 | Na |
| Zimmer Biomet Holdings, INC. | $216.40 | 2019 | |
| Smith+Nephew, INC. | $170.07 | 2019 | |
| Extremity Medical | $146.33 | 2020 | |
| Sanara Medtech INC. | $135.00 | 2021 | |
| Catalyst Orthoscience | $64.10 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $36.96 | 2025 | |
| Sonex Health, INC. | $34.48 | 2025 | Sx-One Microknife |
| Integra Lifesciences Corporation | $34.35 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endo Pharmaceuticals INC. | $18.55 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.88 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Vial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.